Clinical Trial Update: Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE Trial [NA]

View source ↗

Summary

A randomized Ez-PAVE trial in patients with atherosclerotic cardiovascular disease compares LDL-C targets of <70 mg/dL versus <55 mg/dL using ezetimibe-based co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease

Drugs mentioned

• EZETIMIBE (EZETIMIBE)

Snippet

Sponsor: Yonsei University | Conditions: Atherosclerotic Cardiovascular Disease | NA | Status: COMPLETED